Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON Pharma today announced the successful completion of patient recruitment of its NOX-E36 Phase IIa clinical trial for the treatment of diabetic nephropathy. NOX-E36 is a Spiegelmer® that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand / Monocyte Chemoattractant Protein-1), a pro-inflammatory chemokine that plays an important role in the progression of diabetic nephropathy, the most common single cause of chronic kidney failure and end-stage renal disease.

25 Jul 2013

Study examines incidence rates of type l diabetes in Finnish children

"The incidence of type l diabetes, one of the most prevalent chronic diseases in children, has increased worldwide," write Valma Harjutsalo, Ph.D., of the Diabetes Prevention Unit, Helsinki, Finland, and colleagues, who conducted a study to examine the incidence rates of T1D between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).

24 Jul 2013

Potential breakthrough to help prevent diabetes

The resistance to insulin seen in type 2 diabetics is caused partly by the lack of a protein that has not previously been associated with diabetes. This breakthrough could potentially help to prevent diabetes.

23 Jul 2013

GW Pharmaceuticals to expand marketing authorization for Sativex to France

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.

22 Jul 2013

Researchers discover new functions for PTPN22 gene linked with autoimmune disease

Researchers at the University of Minnesota have identified infection-fighting and inflammation-suppressing functions for a gene associated with human autoimmune disease.

20 Jul 2013

FDA gives tentative approval to Perrigo's ANDA for generic version of Prandin Tablets

Perrigo Company today announced that it has received tentative approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets (repaglinide tablets).

20 Jul 2013

New research uncovers biological ties between obesity and asthma

Genes linked to chronic inflammation in asthma may be more active in people who are obese, according to new research that uncovers several biological ties between obesity and asthma.

19 Jul 2013

Researchers develop new drug delivery technique for diabetes treatment

Researchers have developed a drug delivery technique for diabetes treatment in which a sponge-like material surrounds an insulin core. The sponge expands and contracts in response to blood sugar levels to release insulin as needed. The technique could also be used for targeted drug delivery to cancer cells.

19 Jul 2013

Transition Therapeutics' ELND005 receives Fast Track Designation from FDA

Transition Therapeutics Inc. announced that the US Food and Drug Administration has granted Fast Track Designation to the development program for ELND005 which was submitted for the treatment of Neuropsychiatric Symptoms in Alzheimer's disease.

18 Jul 2013

TSRI scientists study 3-D structure of glucagon receptor for treatment of diabetes

The study is reported on July 17, 2013, in an advance online edition of the journal Nature, alongside a British laboratory's structural study of another member of the same class of receptors-known as "class B" G protein-coupled receptors (GPCRs).

18 Jul 2013

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

AbGenomics International announced today that it has raised $9.6 million in current financing round.

18 Jul 2013

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Certain chromosomal abnormalities of the preleukemic type appear to be over-represented in patients with type 2 diabetes (T2D) who are suffering from vascular complications. This finding may provide a partial explanation for the higher rates of cancer-related mortality observed among patients with this type of diabetes.

18 Jul 2013

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

People with pre-diabetes who lose roughly 10 percent of their body weight within six months of diagnosis dramatically reduce their risk of developing type 2 diabetes over the next three years, according to results of research led by Johns Hopkins scientists.

17 Jul 2013

Majority of Australians do not know the risk factors associated with diabetes

New research conducted by Medibank 24/7 Health Advice Line reveals the majority (97%) of Australians do not know all the major symptoms of diabetes or how many types there are, despite it affecting 3.6 million people nationwide and costing the economy $6 billion per year.

16 Jul 2013

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2 diabetes.

16 Jul 2013

Obese fathers may pass their obesity to children and grandchildren

New research from the University of Adelaide shows that the sperm of obese fathers could increase the risk of both their children and their grandchildren to inherit obesity.

16 Jul 2013

ACOEM, ACPM urge adoption of stronger national policies for preventive medicine

The American College of Occupational and Environmental Medicine and the American College of Preventive Medicine urged the adoption of stronger national policies to encourage preventive medicine - including in the workplace -- during a special Congressional briefing Tuesday, July 9 in Washington, D.C.

15 Jul 2013

Scientists uncover mechanism that controls cell death processes

Scientists have uncovered the mechanism that controls whether cells that are able to suppress immune responses live or die.

15 Jul 2013

‘Risking It’ campaign to raise awareness on coronary heart disease

A health expert from Sheffield Hallam University has become the face of a national campaign against heart disease after making significant improvements to his own lifestyle.

From Sheffield Hallam University 15 Jul 2013

Scientists successfully transplant insulin-producing cells from one species to another

In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine- scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.

15 Jul 2013

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

Study examines incidence rates of type l diabetes in Finnish children

Potential breakthrough to help prevent diabetes

GW Pharmaceuticals to expand marketing authorization for Sativex to France

Researchers discover new functions for PTPN22 gene linked with autoimmune disease

FDA gives tentative approval to Perrigo's ANDA for generic version of Prandin Tablets

New research uncovers biological ties between obesity and asthma

Researchers develop new drug delivery technique for diabetes treatment

Transition Therapeutics' ELND005 receives Fast Track Designation from FDA

TSRI scientists study 3-D structure of glucagon receptor for treatment of diabetes

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

Majority of Australians do not know the risk factors associated with diabetes

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Obese fathers may pass their obesity to children and grandchildren

ACOEM, ACPM urge adoption of stronger national policies for preventive medicine

Scientists uncover mechanism that controls cell death processes

‘Risking It’ campaign to raise awareness on coronary heart disease

Scientists successfully transplant insulin-producing cells from one species to another

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in